Cite
Zarkavelis G, Kotoula V, Kolliou GA, et al. Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG). ESMO Open. 2019;4(5):e000525doi: 10.1136/esmoopen-2019-000525.
Zarkavelis, G., Kotoula, V., Kolliou, G. A., Papadopoulou, K., Tikas, I., Karavasilis, V., Samantas, E., Dervenis, C., Efstratiou, I., Nicolaou, I., Apessou, D., Kafiri, G., Koletsa, T., Bompolaki, I., Rallis, G., Batistatou, A., Glantzounis, G., Pectasides, D., Fountzilas, G., & Pentheroudakis, G. (2019). Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG). ESMO open, 4(5), e000525. https://doi.org/10.1136/esmoopen-2019-000525
Zarkavelis, George, et al. "Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG)." ESMO open vol. 4,5 (2019): e000525. doi: https://doi.org/10.1136/esmoopen-2019-000525
Zarkavelis G, Kotoula V, Kolliou GA, Papadopoulou K, Tikas I, Karavasilis V, Samantas E, Dervenis C, Efstratiou I, Nicolaou I, Apessou D, Kafiri G, Koletsa T, Bompolaki I, Rallis G, Batistatou A, Glantzounis G, Pectasides D, Fountzilas G, Pentheroudakis G. Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG). ESMO Open. 2019 Sep 18;4(5):e000525. doi: 10.1136/esmoopen-2019-000525. eCollection 2019. PMID: 31673425; PMCID: PMC6802956.
Copy
Download .nbib